6 May
2011
6 May
'11
10:43 a.m.
Hi Thomas et al.
I'll join. Petr is on holidays but has sent his comments on the topic list which I cc
below.
Bw GJ
1. As of now we made plans that the different labs analyze samples from one particular
population (as listed in the workflow document that I've sent around on April 7).
It would be a better experimental design if the samples were randomly distributed among
the different labs. Since there is still time to react - do we want to switch the
strategy?
I would say the random design is preferred.
2. How long are the library prep / sequencer queue up times in the different labs (once
you receive the RNA samples - how long do you think will it take you to analyze them?).
If some labs expect to have much larger delays, we could make arrangements that those labs
get samples earlier than other labs.
This would also mean that we would all use the protocol that is used at the time point
when the first lab starts to analyze samples.
3-4 months
3. Which other samples (other than the 500 1KGP European samples) should be analyzed by
RNAseq?
Disease related samples for which we are also analyzing exomes, e.g. intestinal expression
profiles for IBD
4. Specifications for the small RNA protocol.
We suggest 36 cycles single end sequencing aiming for at least 3 million reads per
sample.
Prof dr GertJan B. van Ommen
Head, Department of Human Genetics
Center for Human and Clinical Genetics
Leiden University Medical Center
Director, Center For Medical Systems Biology
Visiting address: Building 2, Zone S-4-P, Room S04-046
Einthovenweg 20
P.O.Box 9600, 2300 RC Leiden NL
Tel +31-71-526 9401 / 9400
Fax +31-71-526 8285
Email gjvo@lumc.nl<mailto:gjvo@lumc.nl>
Website: <http://www.humgen.nl>; <http://www.cmsb.nl>
===========
NB: This communication is intended for use by the addressee. It may contain confidential
or privileged information. Therefore no right or title whatsoever shall be deemed to have
given regarding the content of the communication or its enclosures. If you receive this
communication unintentionally, please immediately notify the sender and delete the
original, copies and enclosures.
From: geuvadis_rnaseq-bounces(a)lists.crg.es [mailto:geuvadis_rnaseq-bounces@lists.crg.es]
On Behalf Of Thomas Giger
Sent: vrijdag 6 mei 2011 10:38
To: geuvadis_rnaseq(a)lists.crg.es
Subject: [Geuvadis_rnaseq] Geuvadis RNAseq TC 11am - local Access numbers
Dear All,
please find attached to this message the local Access numbers for joining the TC at 11am.
cheers,
Thomas
Begin forwarded message:
From: Thomas Giger <Thomas.Giger@unige.ch<mailto:Thomas.Giger@unige.ch>>
Date: April 26, 2011 11:27:49 AM GMT+02:00
To: geuvadis_rnaseq@lists.crg.es<mailto:geuvadis_rnaseq@lists.crg.es>, Manolis
Dermitzakis
<Emmanouil.Dermitzakis@unige.ch<mailto:Emmanouil.Dermitzakis@unige.ch>>
Subject: [Geuvadis_rnaseq] Geuvadis RNAseq TC details
Dear All,
thank you for having filled in the doodle.
The Geuvadis RNAseq phone conference will take place on May 6 from 11am - 12pm CEST.
To participate in this call you have to do the following:
- if you call in from Switzerland dial: +41 58 262 07 22
- otherwise from other countries please find enclosed the list with the
"local access numbers for teleconferences" and dial the number corresponding to
your country.
Then enter the PIN: 611683
In case you need assistance during the call - dial "OO" (nil nil) to get in
touch with an operator.
I have written down the following points that should be discussed:
1. As of now we made plans that the different labs analyze samples from one particular
population (as listed in the workflow document that I've sent around on April 7).
It would be a better experimental design if the samples were randomly distributed among
the different labs. Since there is still time to react - do we want to switch the
strategy?
2. How long are the library prep / sequencer queue up times in the different labs (once
you receive the RNA samples - how long do you think will it take you to analyze them?).
If some labs expect to have much larger delays, we could make arrangements that those labs
get samples earlier than other labs.
This would also mean that we would all use the protocol that is used at the time point
when the first lab starts to analyze samples.
3. Which other samples (other than the 500 1KGP European samples) should be analyzed by
RNAseq?
4. Specifications for the small RNA protocol.
If you already know now, that you would like to have additional things discussed - please
let me know and I can make sure that we don't forget about.
Looking forward to talk to you soon,
Thomas